{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:03:42Z","timestamp":1792904622880,"version":"4.5.0"},"reference-count":162,"publisher":"American Chemical Society (ACS)","issue":"25","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug repurposing is a method of investigating new therapeutic applications for previously approved medications. This repurposing approach to \u201cold\u201d medications is now highly efficient, simple to arrange, and cost-effective and poses little risk of failure in treating a variety of disorders, including cancer. Drug repurposing for cancer therapy is currently a key topic of study. It is a way of exploring recent therapeutic applications for already-existing drugs. Theoretically, the repurposing strategy has various advantages over the recognized challenges of creating new molecular entities, including being faster, safer, easier, and less expensive. In the real world, several medications have been repurposed, including aspirin, metformin, and chloroquine. However, doctors and scientists address numerous challenges when repurposing drugs, such as the fact that most drugs are not cost-effective and are resistant to bacteria. So the goal of this review is to gather information regarding repurposing pharmaceuticals to make them more cost-effective and harder for bacteria to resist. Cancer patients are more susceptible to bacterial infections. Due to their weak immune systems, antibiotics help protect them from a variety of infectious diseases. Although antibiotics are not immune boosters, they do benefit the defense system by killing bacteria and slowing the growth of cancer cells. Their use also increases the therapeutic efficacy and helps avoid recurrence. Of late, antibiotics have been repurposed as potent anticancer agents because of the evolutionary relationship between the prokaryotic genome and mitochondrial DNA of eukaryotes. Anticancer antibiotics that prevent cancer cells from growing by interfering with their DNA and blocking growth of promoters, which include anthracyclines, daunorubicin, epirubicin, mitoxantrone, doxorubicin, and idarubicin, are another type of FDA-approved antibiotics used to treat cancer. According to the endosymbiotic hypothesis, prokaryotes and eukaryotes are thought to have an evolutionary relationship. Hence, in this study, we are trying to explore antibiotics that are necessary for treating diseases, including cancer, helping people reduce deaths associated with various infections, and substantially extending people\u2019s life expectancy and quality of life.<\/jats:p>","DOI":"10.1021\/acsomega.4c00617","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:09:55Z","timestamp":1718298595000},"page":"26762-26779","source":"Crossref","is-referenced-by-count":26,"title":["Drug Repurposing of Selected Antibiotics: An Emerging\nApproach in Cancer Drug Discovery"],"prefix":"10.1021","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5242-636X","authenticated-orcid":true,"given":"Nilofer","family":"Bano","sequence":"first","affiliation":[{"name":"Integral University , , Kursi Road , ,","place":["Lucknow, India, 226026"]},{"name":"Integral University , , Kursi Road , ,","place":["Lucknow, India, 226026"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Parveen","sequence":"additional","affiliation":[{"name":"Integral University , , Kursi Road , ,","place":["Lucknow, India, 226026"]},{"name":"Integral University , , Kursi Road , ,","place":["Lucknow, India, 226026"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saeed","sequence":"additional","affiliation":[{"name":"University of Hail , , P.O. Box 2240, ,","place":["Hail, Saudi Arabia, 55476"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"University of Hail , , ,","place":["Hail, Saudi Arabia, 55476"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[{"name":"King Khalid University , , ,","place":["Abha, Saudi Arabia, 61421"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snober S.","family":"Mir","sequence":"additional","affiliation":[{"name":"Integral University , , Kursi Road , ,","place":["Lucknow, India, 226026"]},{"name":"Integral University , , Kursi Road , ,","place":["Lucknow, India, 226026"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"2026081709083293600_cit1","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1200\/JCO.2009.27.4944","article-title":"Clinical implications of the cancer genome","volume":"28","author":"MacConaill","year":"2010","journal-title":"J. ClinOncol."},{"key":"2026081709083293600_cit2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020. GLOBOCAN\nestimates of incidence and mortality worldwide for 36 cancers in 185\ncountries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"2026081709083293600_cit3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1475-2867-6-25","article-title":"Stem cells,\nsenescence, neosis and self-renewal in cancer","volume":"6","author":"Rajaraman","year":"2006","journal-title":"Cancer Cell Int."},{"key":"2026081709083293600_cit4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0149-2918(00)88288-0","article-title":"Trastuzumab,\na recombinant DNA-derived humanized monoclonal antibody, a novel agent\nfor the treatment of metastatic breast cancer","volume":"21","author":"Goldenberg","year":"1999","journal-title":"ClinTher."},{"key":"2026081709083293600_cit5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"2026081709083293600_cit6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Nitrogen mustard therapy: Use of methyl-bis (beta-chloroethyl)\naminehydrochloride and tris (beta-chloroethyl) amine hydrochloride\nfor hodgkin\u2019s disease, lymphosarcoma, leukemia and certain\nallied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"JAMA"},{"key":"2026081709083293600_cit7","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.7314\/APJCP.2014.15.13.5137","article-title":"Down-regulation of miRNA-452 is Associated\nwith Adriamycin-resistance\nin Breast Cancer Cells","volume":"15","author":"Qing","year":"2014"},{"key":"2026081709083293600_cit8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ja.2013.49","article-title":"Prospects for new antibiotics: a\nmolecule-centered\nperspective","volume":"67","author":"Walsh","year":"2014","journal-title":"J. Antibiot."},{"key":"2026081709083293600_cit9","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.7150\/jca.47470","article-title":"Antibiotics\nfor cancer\ntreatment: A double-edged sword","volume":"11","author":"Gao","year":"2020","journal-title":"J. Cancer"},{"key":"2026081709083293600_cit10","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-14027-8","volume-title":"New Approaches to Natural\nAnticancer Drugs","author":"Saeidnia","year":"2015"},{"key":"2026081709083293600_cit11","article-title":"Doxorubicin","volume-title":"StatPearls [Internet]","author":"Johnson-Arbor","year":"2023"},{"key":"2026081709083293600_cit12","article-title":"Mitomycin","volume-title":"StatPearls [Internet]","author":"Sinawe","year":"2022"},{"key":"2026081709083293600_cit13","article-title":"Daunorubicin","volume-title":"StatPearls [Internet]","author":"Saleem","year":"2022"},{"key":"2026081709083293600_cit14","first-page":"159","article-title":"Idarubicin in the treatment\nof acute leukemias, an overview of preclinical and clinical studies","volume":"75","author":"Carella","year":"1990","journal-title":"Haematologica"},{"key":"2026081709083293600_cit15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1186\/s12885-021-09050-6","article-title":"Effectiveness and safety\nof pegylated\nliposomal doxorubicin versus epirubicin as neoadjuvant or adjuant\n chemotherapy for breast cancer: a real-world study","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"2026081709083293600_cit16","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/1078-0432.CCR-07-0944","article-title":"Treatmentofhormonerefractoryprostatecancerwithdocetaxelormitoxantrone:relationshipsbetweenprostate-specificantigen,pain,andqualityoflife\nresponseandsurvivalintheTAX-327study","volume":"14","author":"Berthold","year":"2008","journal-title":"J. Clin\nCancer Res."},{"key":"2026081709083293600_cit17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrclinonc.2015.169","article-title":"Drug repurposing in oncology--patient\nand health systems opportunities. Nature reviews","volume":"12","author":"Bertolini","year":"2015","journal-title":"J. Clinical oncology."},{"key":"2026081709083293600_cit18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/leu.2016.343","article-title":"Diagnosis and relapse: Cytogenetically\nnormal acute myelogenous leukemia without FLT3- ITD\nor MLL-PTD","volume":"31","author":"Chien","year":"2017","journal-title":"Leukemia"},{"key":"2026081709083293600_cit19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1586\/14737140.2015.1115350","article-title":"Valrubicin in refractory non-muscle\ninvasive bladder cancer. Expert Rev","volume":"15","author":"Sharma","year":"2015","journal-title":"J. Anticancer\nTherapy."},{"key":"2026081709083293600_cit20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1634\/theoncologist.2013-0020","article-title":"The European Medicines Agency review\nof pixantrone for the treatment of adult patients with multiple relapsed\nor refractory aggressive non- Hodgkin\u2019s B-cell lymphomas: summary\nof the scientific assessment of the committee for medicinal products\nfor human use","volume":"18","author":"Pean","year":"2013","journal-title":"J. Oncologist."},{"key":"2026081709083293600_cit21","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.18632\/oncotarget.2657","article-title":"Metformin and salinomycin\nas the best combination for the eradication of NSCLC monolayer cells\nand their alveospheres (cancer stem cells) irrespective of EGFR, KRAS,\nEML4\/ALK and LKB1 status","volume":"5","author":"Xiao","year":"2014","journal-title":"J. Oncotarget."},{"key":"2026081709083293600_cit22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.toxlet.2013.07.022","article-title":"Salinomycin induces\napoptosis in cisplatin-resistant colorectal cancer cells by accumulation\nof reactive oxygen species","volume":"222","author":"Zhou","year":"2013","journal-title":"J. Toxicol. Lett."},{"key":"2026081709083293600_cit23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/cdd.2013.123","article-title":"The EMT activator ZEB1 promotes tumor\ngrowth and determines differential response to chemotherapy in mantle\ncell lymphoma","volume":"21","author":"Sa\u0301nchez-Tillo\u0301","year":"2014","journal-title":"Cell Death and Differentiation."},{"key":"2026081709083293600_cit24","article-title":"Anthracyclines","volume-title":"StatPearls [Internet]","author":"Venkatesh","year":"2023"},{"key":"2026081709083293600_cit25","article-title":"Tetracycline","volume-title":"StatPearls [Internet]","author":"Shutter","year":"2022"},{"key":"2026081709083293600_cit26","unstructured":"Fluoroquinolones. In LiverTox: Clinical and\nResearch Information on Drug-Induced Liver Injury [Internet]; National Institute of Diabetes and Digestive and\nKidney Diseases: Bethesda, MD, Updated 2020 Mar 10. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547840\/."},{"key":"2026081709083293600_cit27","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone\nantibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"J. Med. chemcomm."},{"key":"2026081709083293600_cit28","article-title":"Macrolides","volume-title":"StatPearls\n[Internet]","author":"Patel"},{"key":"2026081709083293600_cit29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved Glycopeptide\nAntibacterial Drugs: Mechanism of Action and Resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"J. Cold Spring HarbPerspect Med."},{"key":"2026081709083293600_cit30","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1128\/AAC.44.12.3249-3256.2000","article-title":"Aminoglycosides:\nPerspectives on\nmechanisms of action and resistance and strategies to counter resistance","volume":"44","author":"Kotra","year":"2000","journal-title":"J. Antimicrob Agents Chemother."},{"key":"2026081709083293600_cit31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/AAC.00892-19","article-title":"Safety, Tolerability,\nPharmacokinetics,\nand Drug Interaction Potential of SPR741, an Intravenous Potentiator,\nafter Single and Multiple Ascending Doses and When Combined with \u03b2-Lactam\nAntibiotics in Healthy Subjects","volume":"63","author":"Eckburg","year":"2019","journal-title":"J. Antimicrobial\nAgents Chemother"},{"key":"2026081709083293600_cit32","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past,\npresent, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"J. Antimicrob Agents Chemother."},{"key":"2026081709083293600_cit33","article-title":"Cephalosporins","volume-title":"StatPearls [Internet]","author":"Bui","year":"2023"},{"key":"2026081709083293600_cit34","article-title":"Chloramphenicol","volume-title":"LiverTox: Clinical and Research\nInformation on Drug-Induced Liver Injury [Internet]","year":"2017"},{"key":"2026081709083293600_cit35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide\ndrugs: structure, antibacterial property,\ntoxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"J. Biophys\nRev."},{"key":"2026081709083293600_cit36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.chemosphere.2013.11.038","article-title":"Biocompatibility and antibacterial activity of photolytic products\nof sulfonamides","volume":"100","author":"Zessel","year":"2014","journal-title":"J. Chemosphere."},{"key":"2026081709083293600_cit37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1615\/JEnvironPatholToxicolOncol.v30.i1.30","article-title":"Oleanolic acid induces\napoptosis by modulating p53,\nBax, Bcl-2 and caspase-3 gene expression and regulates the activation\nof transcription factors and cytokine profile in B16F","volume":"30","author":"Pratheeshkumar","year":"2011","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"2026081709083293600_cit38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1097-0142(197002)25:2&lt;389::AID-CNCR2820250217&gt;3.0.CO;2-X","article-title":"Mithramycin treatment of hypercalcemia","volume":"25","author":"Perlia","year":"1970","journal-title":"J.\nCancer."},{"key":"2026081709083293600_cit39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/1097-0142(197304)31:4&lt;889::AID-CNCR2820310419&gt;3.0.CO;2-H","article-title":"Mithramycin\nin the treatment of metastatic\nEwing\u2019s sarcoma","volume":"31","author":"Kofman","year":"1973","journal-title":"J. Cancer."},{"key":"2026081709083293600_cit40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/00024677-200302040-00005","article-title":"Current management\nstrategies for\nhypercalcemia","volume":"2","author":"Pecherstorfer","year":"2003","journal-title":"J. Treatments in endocrinology."},{"key":"2026081709083293600_cit41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","article-title":"Sp1 transcription\nfactor: a long-standing\ntarget in cancer chemotherapy","volume":"152","author":"Vizcaino","year":"2015","journal-title":"J. PharmacolTher."},{"key":"2026081709083293600_cit42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114894","article-title":"Mithramycin suppresses\ntumor growth by regulating CD47 and PD-L1 expression","volume":"197","author":"Gong","year":"2022","journal-title":"J. BiochemPharmacol."},{"key":"2026081709083293600_cit43","first-page":"29","article-title":"Effect of deficiencies\nin DNA repair\non the toxicity of mitomycin C and porfiromycin to CHO cells under\naerobic and hypoxic conditions","volume":"3","author":"Hughes","year":"1991","journal-title":"J. Cancer communications."},{"key":"2026081709083293600_cit44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.critrevonc.2012.12.003","article-title":"Revisiting bleomycin from pathophysiology to safe clinical\nuse","volume":"87","author":"Froudarakis","year":"2013","journal-title":"Crit Rev. J. OncolHematol."},{"key":"2026081709083293600_cit45","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00210-016-1253-3","article-title":"Aliskiren\nattenuates bleomycin- induced\npulmonary fibrosis in rats: focus on oxidative stress, advanced glycation\nend products, and matrix metalloproteinase-9","volume":"389","author":"Abuelezz","year":"2016","journal-title":"J. NaunynSchmiedebergs Arch. Pharmacol."},{"key":"2026081709083293600_cit46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","article-title":"Bleomycin\nin the setting of lung fibrosis induction: From biological mechanisms\nto counteractions","volume":"97","author":"Della\nLatta","year":"2015","journal-title":"J. Pharmacol. Res."},{"issue":"22","key":"2026081709083293600_cit47","doi-asserted-by":"publisher","first-page":"11636","DOI":"10.1016\/S0021-9258(19)68452-8","article-title":"Activated\nbleomycin. A transient\ncomplex of drug, iron, and oxygen that degrades DNA","volume":"256","author":"Burger","year":"1981","journal-title":"J. The Journal of Biological Chemistry."},{"key":"2026081709083293600_cit48","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10495-015-1119-z","article-title":"Mitochondrial DNA\ndamage by bleomycin induces aml cell\ndeath","volume":"20","author":"Yeung","year":"2015","journal-title":"J. Apoptosis."},{"key":"2026081709083293600_cit49","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3109\/10428194.2013.848984","article-title":"Treatment with cyclophosphamide,\nvindesine, cytarabine, dexamethasone\nand bleomycin in patients with relapsed\/refractory diffuse large b-cell\nlymphoma","volume":"55","author":"Li","year":"2014","journal-title":"J. Leuk Lymphoma."},{"key":"2026081709083293600_cit50","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10620-012-2470-3","article-title":"Smad3 and\nsmad3 phosphoisoforms are prognostic markers of gastric carcinoma","volume":"58","author":"Kim","year":"2013","journal-title":"J. Dig Dis. Sci."},{"key":"2026081709083293600_cit51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2016.05.007","article-title":"Fcn2 inhibits epithelial- mesenchymal\ntransition-induced metastasis\nof hepatocellular carcinoma via tgf-beta\/smad signaling","volume":"378","author":"Yang","year":"2016","journal-title":"J. Cancer Lett."},{"key":"2026081709083293600_cit52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s13277-013-1088-1","article-title":"Smad4 is\na potential prognostic marker in human breast carcinomas","volume":"35","author":"Liu","year":"2014","journal-title":"J. Tumour Biol."},{"key":"2026081709083293600_cit53","first-page":"307","article-title":"DNA Topoisomerase II as the Primary\nTarget of Anti-Tumor\nAnthracyclines","volume":"5","author":"Zunino","year":"1990","journal-title":"J. Anti-Cancer Drug Design"},{"key":"2026081709083293600_cit54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/1097-0142(197304)31:4&lt;931::AID-CNCR2820310426&gt;3.0.CO;2-E","article-title":"Daunorubicin-Prednisone\nremission\ninduction with hydroxyurea maintenance in acute nonlymphocytic leukemia","volume":"31","author":"Bloomfield","year":"1973","journal-title":"J. Cancer."},{"key":"2026081709083293600_cit55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.beha.2019.05.005","article-title":"Daunorubicin-cytarabine\nliposome (CPX-351) in the management\nof newly diagnosed secondary AML: A new twist on an old cocktail","volume":"32","author":"Maakaron","year":"2019","journal-title":"Best Pract Res. ClinHaematol"},{"key":"2026081709083293600_cit56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-444-63929-5.00002-4","article-title":"Advances in the Chemistry of Natural\nand Semisynthetic Topoisomerase I\/II Inhibitors","volume":"54","author":"D\u2019yakonov","year":"2017","journal-title":"Studies in natural products chemistry"},{"key":"2026081709083293600_cit57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejpb.2014.12.009","article-title":"Surface functionalized\nmesoporous\nsilica nanoparticles as an effective carrier for epirubicin delivery\nto cancer cells","volume":"89","author":"Hanafi-Bojd","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2026081709083293600_cit58","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1200\/JCO.2017.74.2130","article-title":"Adjuvant chemoradiotherapy with epirubicin,\ncisplatin, and fluorouracil compared with adjuvant chemoradiotherapy\nwith fluorouracil and leucovorin after curative resection of gastric\ncancer: results from CALGB 80101 (Alliance)","volume":"35","author":"Fuchs","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"2026081709083293600_cit59","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejpb.2014.04.016","article-title":"Improved antitumor\nactivity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted\nnanoparticles combined with tocotrienols against hepatocellular carcinoma\nin mice, Europ","volume":"88","author":"Nasr","year":"2014","journal-title":"J. Pharm. Biopharm."},{"key":"2026081709083293600_cit60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.bjc.6690350","article-title":"Long-term\nsurvival after epirubicin,\ncisplatin and fluorouracil for gastric cancer: results of a randomized\ntrial","volume":"80","author":"Waters","year":"1999","journal-title":"J. British Journal of Cancer."},{"key":"2026081709083293600_cit61","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s11095-016-1967-4","article-title":"Targeted\nDelivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System\nin vitro and in vivo","volume":"33","author":"Yazdian-Robati","year":"2016","journal-title":"J. Pharmaceutical Research."},{"key":"2026081709083293600_cit62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejpb.2016.03.013","article-title":"Double targeting\nand aptamer-assisted\ncontrolled release delivery of epirubicin to cancer cells by aptamers-based\ndendrimer in vitro and in vivo","volume":"102","author":"Taghdisi","year":"2016","journal-title":"J. European\nJournal of Pharmaceutics and Biopharmaceutics"},{"key":"2026081709083293600_cit63","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics\nthat target mitochondria effectively eradicate cancer stem cells,\nacross multiple tumor types: Treating cancer like an infectious disease","volume":"6","author":"Lamb","year":"2015","journal-title":"Oncotarget."},{"key":"2026081709083293600_cit64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.vph.2012.01.007","article-title":"Matrix\nmetalloproteinase inhibition therapy for vascular diseases","volume":"56","author":"Newby","year":"2012","journal-title":"J. Vasc. Pharmacol."},{"key":"2026081709083293600_cit65","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","article-title":"Doxycycline\ninhibits the cancer stem\ncell phenotype and epithelial-to-mesenchymal transition in breast\ncancer","volume":"16","author":"Zhang","year":"2017","journal-title":"J. Cell Cycle."},{"key":"2026081709083293600_cit66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjc.6600347","article-title":"Immune changes in patients with advanced\nbreast cancer\nundergoing chemotherapy with taxanes","volume":"87","author":"Tsavaris","year":"2002","journal-title":"Br. J.\nCancer"},{"key":"2026081709083293600_cit67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"J. Sig Transduct Target Ther"},{"key":"2026081709083293600_cit68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.619317","article-title":"Doxycycline\nInhibits Cancer Stem Cell-Like Properties via PAR1\/FAK\/PI3K\/AKT Pathway\nin Pancreatic Cancer","volume":"10","author":"Liu","year":"2021","journal-title":"J. Front. Oncol."},{"key":"2026081709083293600_cit69","first-page":"3041","article-title":"Doxycycline targets\naldehyde dehydrogenase-positive breast cancer stem cells oncology\nreports","volume":"39","author":"Lin","year":"2018"},{"key":"2026081709083293600_cit70","first-page":"425","article-title":"Minocycline in the treatment of acne: latest findings","volume":"145","author":"Maffeis","year":"2010","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"2026081709083293600_cit71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"J. Br Pharmacol."},{"key":"2026081709083293600_cit72","doi-asserted-by":"publisher","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines:\na pleitropic family of compounds with promising therapeutic properties.\nReview of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"J. Am. Physiol Cell\nPhysiol."},{"key":"2026081709083293600_cit73","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.3390\/ijms21186917","article-title":"Cellular and\nMolecular Aspects of Anti-Melanoma Effect of Minocycline-A Study of\nCytotoxicity and Apoptosis on Human Melanotic Melanoma Cells","volume":"21","author":"Rok","year":"2020","journal-title":"J. International journal of molecular sciences."},{"key":"2026081709083293600_cit74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainresbull.2017.04.010","article-title":"Neuroprotective\neffect of minocycline on cognitive impairments induced by transient\ncerebral ischemia\/reperfusion through its anti-inflammatory and anti-oxidant\nproperties in male rat","volume":"131","author":"Naderi","year":"2017","journal-title":"Brain. Res. Bull."},{"key":"2026081709083293600_cit75","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ijms23020831","article-title":"The Anticancer\nPotential of Doxycycline and Minocycline.\nA Comparative Study on Amelanotic Melanoma Cell Lines","volume":"23","author":"Rok","year":"2022","journal-title":"J. Int. J. Mol. Sci."},{"key":"2026081709083293600_cit76","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1161\/01.ATV.20.12.2527","article-title":"Mitogen-activated protein kinases\nmediate matrix metalloproteinase-9 expression in vascular smooth muscle\ncells","volume":"20","author":"Cho","year":"2000","journal-title":"J. ArteriosclerThrombVasc Biol."},{"key":"2026081709083293600_cit77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060817","article-title":"Minocycline\nSuppresses Interleukine-6,\nIts Receptor System and Signaling Pathways and Impairs Migration,\nInvasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and\nIn Vivo Studies","volume":"8","author":"Ataie-Kachoie","year":"2013","journal-title":"J. PLoS ONE"},{"key":"2026081709083293600_cit78","doi-asserted-by":"publisher","first-page":"e00073","DOI":"10.1128\/AAC.00073-17","article-title":"In Vitro\nAssessment of Combined Polymyxin B and Minocycline Therapy against\nKlebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae","volume":"61","author":"Huang","year":"2017","journal-title":"J. Antimicrob Agents Chemother."},{"key":"2026081709083293600_cit79","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1128\/AAC.01499-05","article-title":"Functional, biophysical,\nand structural bases for antibacterial activity of tigecycline","volume":"50","author":"Olson","year":"2006","journal-title":"J. Antimicrob Agents Chemother"},{"key":"2026081709083293600_cit80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jmii.2011.01.009","article-title":"Clinical experience\nwith tigecycline as treatment for\nserious infections in elderly and critically ill patients","volume":"44","author":"Kuo","year":"2011","journal-title":"J. MicrobiolImmunol Infect."},{"key":"2026081709083293600_cit81","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13046-017-0512-6","article-title":"Inhibition of autophagy enhances\nthe selective anti-cancer activity\nof tigecycline to overcome drug resistance in the treatment of chronic\nmyeloid leukemia","volume":"36","author":"Lu","year":"2017","journal-title":"J. Journal of Experimental\n& Clinical Cancer Research"},{"key":"2026081709083293600_cit82","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3390\/ijms20143577","article-title":"Biological functions and molecular mechanisms of antibiotic tigecycline\nin the treatment of cancers","volume":"20","author":"Dong","year":"2019","journal-title":"J. Int. Mol. Sci."},{"key":"2026081709083293600_cit83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fphar.2016.00473","article-title":"The antibiotic drug\ntigecycline: a focus on its promising anticancer properties","volume":"7","author":"Xu","year":"2017","journal-title":"J. Front Pharmacol."},{"key":"2026081709083293600_cit84","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition\nof mitochondrial translation as a therapeutic strategy for human acute\nmyeloid leukemia","volume":"20","author":"Skrtic","year":"2011","journal-title":"J. Cancer Cell."},{"key":"2026081709083293600_cit85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13046-017-0512-6","article-title":"Inhibition of autophagy\nenhances the selective anti-cancer activity\nof tigecycline to overcome drug resistance in the treatment of chronic\nmyeloid leukemia","volume":"36","author":"Lu","year":"2017","journal-title":"J. Journal of experimental\n& clinical cancer research."},{"key":"2026081709083293600_cit86","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1200\/JCO.2003.09.047","article-title":"Combination of fludarabine and mitoxantrone in untreated\nstages III and IV low-grade lymphoma: 5950","volume":"21","author":"Velasquez","year":"2003","journal-title":"J. Clinical Oncol."},{"key":"2026081709083293600_cit87","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1021\/bi00336a034","article-title":"Characteristics\nof the binding of the anticancer agents\u2019 mitoxantrone and ametantrone\nand related structures to deoxyribonucleic acids","volume":"24","author":"Lown","year":"1985","journal-title":"J. Biochemistry."},{"key":"2026081709083293600_cit88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/1573406054368738","article-title":"Topoisomerase enzymes as therapeutic targets for cancer\nchemotherapy","volume":"1","author":"Giles","year":"2005","journal-title":"J. Med. Chem."},{"key":"2026081709083293600_cit89","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0014-5793(86)80703-7","article-title":"DNA sequence\npreferences for the anti-cancer drug mitoxanthrone and related anthraquinones\nrevealed by DNase I footprinting","volume":"202","author":"Fox","year":"1986","journal-title":"J. FEBS Lett."},{"key":"2026081709083293600_cit90","doi-asserted-by":"publisher","first-page":"13343","DOI":"10.1021\/acsnano.0c05194","article-title":"Liposomal Delivery of Mitoxantrone\nand a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy\nin Multiple Solid Tumors","volume":"14","author":"Mei","year":"2020","journal-title":"J. ACS Nano."},{"key":"2026081709083293600_cit91","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41419-020-03153-x","article-title":"Combined treatment\nof mitoxantrone sensitizes breast cancer cells to rapalogs through\nblocking eEF-2K-mediated activation of Akt and autophagy","volume":"11","author":"Guan","year":"2020","journal-title":"J. Cell Death and Disease."},{"key":"2026081709083293600_cit92","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fmolb.2015.00009","article-title":"Using docking\nand alchemical free energy approach to determine the binding mechanism\nof eEF2K inhibitors and prioritizing the compound synthesis","volume":"2","author":"Wang","year":"2015","journal-title":"J. Front. Mol. Biosci."},{"key":"2026081709083293600_cit93","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1038\/onc.2016.166","article-title":"eEF-2 kinase\nis a critical regulator of Warburg effect through controlling PP2A-A\nsynthesis","volume":"35","author":"Cheng","year":"2016","journal-title":"J. Oncogene."},{"key":"2026081709083293600_cit94","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","article-title":"Repositioning of fluoroquinolones\nfrom antibiotic to\nanti-cancer agents: An underestimated truth","volume":"111","author":"Yadav","year":"2019","journal-title":"J. Biomedicine & Pharmacotherapy."},{"key":"2026081709083293600_cit95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00109-013-1083-4","article-title":"Gemifloxacin inhibits\nmigration and invasion and induces\nmesenchymal-epithelial transition in human breast adenocarcinoma cells","volume":"92","author":"Chen","year":"2014","journal-title":"J. Mol. Med. (Berl)."},{"key":"2026081709083293600_cit96","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ijantimicag.2004.02.017","article-title":"Antimicrobial\nselection for community acquired lower respiratory tract infections\nin the 21st century: a review of gemifloxacin","volume":"23","author":"Appelbaum","year":"2004","journal-title":"J. Int. J. Antimicrob Agents."},{"key":"2026081709083293600_cit97","doi-asserted-by":"publisher","first-page":"e47796","DOI":"10.1371\/journal.pone.0047796","article-title":"Gemifloxacin induces\nS and G2-phase cell cycle arrest in pancreatic cancer cells via p21\/p27\/p53","volume":"7","author":"Yadav","year":"2012","journal-title":"J. plos one."},{"key":"2026081709083293600_cit98","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ccr.2013.03.022","article-title":"Mutant p53\nprolongs NF-\u03baB activation\nand promotes chronic inflammation and inflammation-associated colorectal\ncancer","volume":"23","author":"Cooks","year":"2013","journal-title":"J. Cancer Cell."},{"key":"2026081709083293600_cit99","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3389\/fonc.2020.613470","article-title":"RNF20 is critical for\nsnail- mediated E-Cadherin repression in human\nbreast cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"2026081709083293600_cit100","doi-asserted-by":"publisher","first-page":"159786","DOI":"10.1155\/2013\/159786","article-title":"Gemifloxacin,\na fluoroquinolone antimicrobial drug, inhibits migration and invasion\nof human colon cancer cells","volume":"2013","author":"Kan","year":"2013","journal-title":"BioMed Res. Int."},{"key":"2026081709083293600_cit101","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1517\/17460440802661443","article-title":"broad-spectrum and\npromising biologically active molecules for the control of drug-resistant\nbacteria and parasites. Polyether ionophores","volume":"4","author":"Kevin","year":"2009","journal-title":"J. Expert Opin Drug Discovery"},{"key":"2026081709083293600_cit102","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/AAC.9.4.655","article-title":"Salinomycin\nEffects on Mitochondrial Ion Translocation and Respiration","volume":"9","author":"Mitani","year":"1976","journal-title":"J. Antimicrob Agents Chemother."},{"key":"2026081709083293600_cit103","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.2174\/15672050113109990199","article-title":"Salinomycin:\na novel\nanti-cancer agent with known anti-coccidial activities","volume":"20","author":"Zhou","year":"2013","journal-title":"J. Curr. Med. Chem."},{"key":"2026081709083293600_cit104","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors\nof cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"J. Cell."},{"key":"2026081709083293600_cit105","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejmech.2018.12.057","article-title":"Medicinal Chemistry Perspective on\nSalinomycin as a\nPotent Anticancer and Anti-CSCs Agent","volume":"164","author":"Antoszczak","year":"2019","journal-title":"J. Eur.\nJ. Med. Chem."},{"key":"2026081709083293600_cit106","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1021\/acscentsci.8b00257","article-title":"The molecular basis for inhibition of stem like cancer\ncells by Salinomycin","volume":"4","author":"Huang","year":"2018","journal-title":"J. ACS Cent. Sci."},{"key":"2026081709083293600_cit107","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2011.07.016","article-title":"Salinomycin inhibits\nosteosarcoma\nby targeting its tumor stem cells","volume":"311","author":"Tang","year":"2011","journal-title":"J. Cancer\nLett."},{"key":"2026081709083293600_cit108","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/15548627.2017.1327104","article-title":"An iron hand over cancer stem cells","volume":"13","author":"Hamai","year":"2017","journal-title":"J. Autophagy."},{"key":"2026081709083293600_cit109","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3329\/bjsir.v50i4.25833","article-title":"In-vitro evaluation of Ciprofloxacin\nHydrochloride. Bangladesh","volume":"50","author":"Jaman","year":"2015","journal-title":"J. Sci. Ind. Res."},{"key":"2026081709083293600_cit110","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination\ntherapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"J. Clin.Microbiol"},{"key":"2026081709083293600_cit111","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone\naction and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"J. Biochemistry"},{"key":"2026081709083293600_cit112","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphar.2017.00546","article-title":"Interplay of the\nQuality of Ciprofloxacin\nand Antibiotic Resistance in Developing Countries","volume":"21","author":"Sharma","year":"2017","journal-title":"J. Front Pharmacol."},{"key":"2026081709083293600_cit113","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-5347(01)66516-9","article-title":"Inhibition of human\ntransitional cell carcinoma in vitro proliferation by fluoroquinolone\nantibiotics","volume":"155","author":"Seay","year":"1996","journal-title":"J. Urol."},{"key":"2026081709083293600_cit114","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces\napoptosis and inhibits proliferation of human colorectal carcinoma\ncells","volume":"86","author":"Herold","year":"2002","journal-title":"J. Br J. Cancer."},{"key":"2026081709083293600_cit115","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","volume":"3","author":"Dalhoff","year":"2003","journal-title":"Immunomodulatory effects\nof quinolones"},{"key":"2026081709083293600_cit116","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pharep.2017.07.007","article-title":"Ciprofloxacin-mediated\ninduction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma\ncells","volume":"70","author":"Beberok","year":"2018","journal-title":"Pharmacological Reports"},{"key":"2026081709083293600_cit117","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1038\/sj.onc.1203773","article-title":"Synergistic\nactivation\nof p53-dependent transcription by two cooperating damage recognition\npathways","volume":"19","author":"Blaydes","year":"2000","journal-title":"J. Oncogene."},{"key":"2026081709083293600_cit118","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/(SICI)1097-4652(199911)181:2&lt;231::AID-JCP5&gt;3.0.CO;2-L","article-title":"The p53 pathway\nand apoptosis","volume":"181","author":"Burns","year":"1999","journal-title":"J. Cell Physiol"},{"key":"2026081709083293600_cit119","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0300-483X(02)00460-2","article-title":"Cell cycle checkpoint\nsignaling:\nCell cycle arrest versus apoptosis","volume":"181\u2013182","author":"Pietenpol","year":"2002","journal-title":"J. Toxicology."},{"key":"2026081709083293600_cit120","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis:\nA review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"J. Toxicol\nPathol."},{"key":"2026081709083293600_cit121","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1016\/j.bmc.2016.07.070","article-title":"New antiproliferative 7-(4-(N-substituted\ncarbamoylmethyl)\u00adpiperazin-1-yl) derivatives of ciprofloxacin induce\ncell cycle arrest at G2\/M phase","volume":"24","author":"Mohammed","year":"2016","journal-title":"J. Bioorganic\n& Medicinal Chemistry"},{"key":"2026081709083293600_cit122","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3892\/ijo.2018.4310","article-title":"Ciprofloxacin triggers the apoptosis\nof human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2\nsignaling pathway","volume":"52","author":"Beberok","year":"2018","journal-title":"J. Int. J. Oncol."},{"key":"2026081709083293600_cit123","first-page":"583","article-title":"Treatment\nof metastatic\ncarcinoid tumor with Dactinomycin or dacarbazine","volume":"67","author":"Van Hazel","year":"1983","journal-title":"J. Cancer Treatment Reports"},{"key":"2026081709083293600_cit124","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/1097-0142(19910515)67:10&lt;2495::AID-CNCR2820671018&gt;3.0.CO;2-8","article-title":"Interaction between dactinomycin\nand tumor necrosis factor in mesothelioma. Cachexia without oncoiysis","volume":"67","author":"Bowman","year":"1991","journal-title":"J. Cancer."},{"key":"2026081709083293600_cit125","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of\ncancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"J. Nat. Med."},{"key":"2026081709083293600_cit126","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101224","article-title":"Hypothesis on the possible\nrelevance of the immunogenic cell death in the treatment of gestational\ntrophoblastic neoplasms","volume":"14","author":"Frega","year":"2021","journal-title":"J. TranslOncol."},{"key":"2026081709083293600_cit127","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911622","article-title":"Inhibition of transcription by dactinomycin\nreveals a new characteristic of immunogenic cell stress","volume":"12","author":"Humeau","year":"2020","journal-title":"J. EMBO Mol. Med."},{"key":"2026081709083293600_cit128","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1020863921840","article-title":"exploring privileged\nstructures: the combinatorial synthesis of cyclic peptides","volume":"16","author":"Horton","year":"2002","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"2026081709083293600_cit129","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0968-0896(97)00062-X","article-title":"Selectivity\nof F8- actinomycin D for RNA: DNA hybrids and its anti-leukemia activity","volume":"5","author":"Takusagawa","year":"1997","journal-title":"J. Bioorg Med. Chem."},{"key":"2026081709083293600_cit130","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/ijo.2015.3237","article-title":"Macrolides sensitize EGFR-TKI-induced non-apoptotic\ncell death via\nblocking autophagy flux in pancreatic cancer cell lines","volume":"48","author":"Mukai","year":"2016","journal-title":"Int. J. Oncol."},{"key":"2026081709083293600_cit131","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40880-018-0309-9","article-title":"Azithromycin enhances anticancer activity of TRAIL\nby inhibiting autophagy and up-regulating the protein levels of DR4\/5\nin colon cancer cells in vitro and in vivo","volume":"38","author":"Qiao","year":"2018","journal-title":"J. Cancer Commun."},{"key":"2026081709083293600_cit132","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/bcj.2016.32","article-title":"Macrolide antibiotics exert antileukemic\neffects by\nmodulating the autophagic flux through inhibition of hERG1 potassium\nchannels","volume":"6","author":"Pillozzi","year":"2016","journal-title":"J. Blood Cancer."},{"key":"2026081709083293600_cit133","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.bbmt.2018.12.097","article-title":"The effect\nof azithromycin on relapse in patients with moderate- severe chronic\ngraft versus host disease (CGVHD)","volume":"25","author":"Shamoun","year":"2019","journal-title":"J. Biol.\nBlood Marrow Transpl."},{"key":"2026081709083293600_cit134","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2165\/00003495-199244050-00007","article-title":"Azithromycin. A review\nof its antimicrobial activity, pharmacokinetic properties and clinical\nefficacy","volume":"44","author":"Peters","year":"1992","journal-title":"J. Drugs."},{"key":"2026081709083293600_cit135","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/cancers4041318","article-title":"Azithromycin synergistically enhances\nanti-proliferative\nactivity of vincristine in cervical and gastric cancer cells","volume":"4","author":"Zhou","year":"2012","journal-title":"J. Cancers."},{"key":"2026081709083293600_cit136","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1111\/cas.14992","article-title":"Azithromycin\nenhances the cytotoxicity of DNA-damaging drugs via lysosomal membrane\npermeabilization in lung cancer cells","volume":"112","author":"Toriyama","year":"2021","journal-title":"J. Cancer\nScience."},{"key":"2026081709083293600_cit137","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/s41416-023-02210-4","article-title":"Azithromycin,\na potent\nautophagy inhibitor for cancer therapy, perturbs cytoskeletal protein\ndynamics","volume":"128","author":"Takano","year":"2023","journal-title":"J. Br. Cancer."},{"key":"2026081709083293600_cit138","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12015-016-9690-4","article-title":"The role of\nautophagy in the maintenance\nof stemness and differentiation of mesenchymal stem cells","volume":"12","author":"Sbrana","year":"2016","journal-title":"J. Stem Cell Rev. Rep."},{"issue":"3","key":"2026081709083293600_cit139","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41419-020-2349-8","article-title":"Clarithromycin inhibits autophagy in colorectal cancer\nby regulating the hERG1 potassium channel interaction with PI3K","volume":"11","author":"Petroni","year":"2020","journal-title":"J. Cell Death Dis."},{"key":"2026081709083293600_cit140","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3332\/ecancer.2015.513","article-title":"Repurposing Drugs in\nOncology (ReDO) - clarithromycin as an anti-cancer agent (ReDO)-clarithromycin\nas an anti-cancer agent","volume":"9","author":"Van Nuffel","year":"2015","journal-title":"ecancer"},{"key":"2026081709083293600_cit141","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1\nforms protein aggregates degraded by autophagy and has a protective\neffect on huntingtin-induced cell death","volume":"171","author":"Bj\u00f8rk\u00f8y","year":"2005","journal-title":"J.\nCell Biol."},{"key":"2026081709083293600_cit142","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1038\/srep03308","article-title":"hERG1 channels\nmodulate integrin signaling to trigger\nangiogenesis and tumor progression in colorectal cancer","volume":"3","author":"Crociani","year":"2013","journal-title":"Sci. Rep."},{"key":"2026081709083293600_cit143","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1126\/scisignal.aaf3236","article-title":"The conformational state of hERG1\nchannels determines\nintegrin association, downstream signaling, and cancer progression","volume":"10","author":"Becchetti","year":"2017","journal-title":"J. Sci. Signal."},{"key":"2026081709083293600_cit144","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00459","article-title":"Wet Cough and Nasal\nSymptoms in Children: Can We Do Better","volume":"7","author":"de Benedictis","year":"2019","journal-title":"J. Frontiers\nin Pediatrics"},{"key":"2026081709083293600_cit145","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12936-016-1114-z","article-title":"Macrolides\nand associated antibiotics based on similar mechanism of action like\nlincosamides in malaria","volume":"15","author":"Gaillard","year":"2016","journal-title":"J. Malar."},{"key":"2026081709083293600_cit146","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11596-011-0146-4","article-title":"Antitumor\nActivity\nof Erythromycin on Human Neuroblastoma Cell Line (SH-SY5Y)","volume":"31","author":"Yongsheng","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technol. [Med. Sci.]"},{"issue":"9","key":"2026081709083293600_cit147","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/onc.2009.512","article-title":"Myc proteins as therapeutic\ntargets","volume":"29","author":"Gustafson","year":"2010","journal-title":"J. Oncogene."},{"issue":"1","key":"2026081709083293600_cit148","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11596-011-0146-4","article-title":"Antitumor activity\nof erythromycin on human neuroblastoma cell line (SH-SY5Y)","volume":"31","author":"Yongsheng","year":"2011","journal-title":"J. HuazhongUnivSciTechnolog Med. Sci."},{"key":"2026081709083293600_cit149","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1093\/carcin\/bgy148","article-title":"Mitochondria in\ncancer: in the aspects\nof tumorigenesis and targeted therapy","volume":"39","author":"Badrinath","year":"2018","journal-title":"J. Carcinogenesis."},{"key":"2026081709083293600_cit150","first-page":"223","article-title":"Overexpression of\nc-Myc inhibits\np21WAF1\/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate\n(TPA)- sensitive human cancer cells","volume":"4","author":"Mitchell","year":"1999","journal-title":"J. Cell\nGrowth Differ."},{"key":"2026081709083293600_cit151","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000445118","article-title":"Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses\nof Chemo resistant Patients with Locally Advanced Head and Neck Squamous\nCell Carcinoma","volume":"90","author":"Juan","year":"2016","journal-title":"J. Oncology"},{"key":"2026081709083293600_cit152","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF00260518","article-title":"Intrinsic antibiotic\nresistance and\ncompetition in fast- and slow-growing soybean rhizobia on a hybrid\nof Asian and US cultivars","volume":"8","author":"Young","year":"1989","journal-title":"J. Biology &\nFertility of Soils."},{"key":"2026081709083293600_cit153","first-page":"479","article-title":"Influence of MP infection on immunologic function in\npatients with chronic obstructive pulmonary disease","volume":"23","author":"Yin","year":"1998","journal-title":"Bulletin of Hunan Medical University"},{"key":"2026081709083293600_cit154","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/ph16111615","article-title":"Origin of\nAntibiotics and Antibiotic Resistance, and Their Impacts on Drug Development:\nA Narrative Review","volume":"16","author":"Muteeb","year":"2023","journal-title":"J. Pharmaceuticals (Basel)."},{"key":"2026081709083293600_cit155","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fmicb.2017.00803","article-title":"Roles of Regulatory\nRNAs for Antibiotic Resistance in Bacteria and Their Potential Value\nas Novel Drug Targets","volume":"8","author":"Dersch","year":"2017","journal-title":"J. Frontiers in Microbiology."},{"key":"2026081709083293600_cit156","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/(SICI)1522-2683(20000401)21:7&lt;1349::AID-ELPS1349&gt;3.0.CO;2-Z","article-title":"Separation\nand determination\nof the macrolide antibiotics (erythromycin, spiramycin and Oleandomycin)\nby capillary electrophoresis coupled with fast reductive voltammetric\ndetection","volume":"21","author":"Zhou","year":"2000","journal-title":"J. Electrophoresis."},{"key":"2026081709083293600_cit157","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ncpendmet0675","article-title":"Therapy Insight: fertility in women\nafter cancer treatment","volume":"3","author":"Morice","year":"2007","journal-title":"Nature Clinical Practice\nEndocrinology & Metabolism"},{"key":"2026081709083293600_cit158","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.7164\/antibiotics.38.1333","article-title":"Lactoquinomycin, a\nnovel anticancer antibiotic. II. Physico-chemical properties and structure\nassignment","volume":"38","author":"Okabe","year":"1985","journal-title":"J. Antibiot."},{"key":"2026081709083293600_cit159","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0006-291X(03)00925-2","article-title":"DNA Cleavage Characteristics\nof Non-Protein\nEnediyne Antibiotic N1999A2","volume":"306","author":"Miyagawa","year":"2003","journal-title":"J. Biochemical\nand Biophysical Research Communications"},{"key":"2026081709083293600_cit160","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2009.04.005","article-title":"A Smart Flower-Like Polymeric Micelle\nfor pH-Triggered Anticancer Drug Release","volume":"375","author":"Oh","year":"2009","journal-title":"J.\nInternational Journal of Pharmaceutics"},{"key":"2026081709083293600_cit161","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1021\/am301600u","article-title":"Synthesis\nof Disulfide-Cross-Linked Polypeptide Nanogel Conjugated with a Near-Infrared\nFluorescence Probe for Direct Imaging of Reduction-Induced Drug Release","volume":"4","author":"Xing","year":"2012","journal-title":"J. ACS Applied Materials & Interfaces"},{"key":"2026081709083293600_cit162","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA Nanoparticles\nContaining Various\nAnticancer Agents and Tumour Delivery by EPR Effect","volume":"63","author":"Acharya","year":"2011","journal-title":"J. Advanced Drug Delivery Reviews"}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.4c00617","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/9\/25\/26762\/4411814\/ao4c00617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/9\/25\/26762\/4411814\/ao4c00617.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:12:32Z","timestamp":1786972352000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/9\/25\/26762\/410144\/Drug-Repurposing-of-Selected-Antibiotics-An"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":162,"journal-issue":{"issue":"25","published-online":{"date-parts":[[2024,6,13]]},"published-print":{"date-parts":[[2024,6,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.4c00617","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}